{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Control+Vehicle&page=14", "query": { "intervention": "Control Vehicle", "page": 14 }, "page_size": 10 }, "pagination": { "page": 14, "page_size": 10, "total_count": 1096, "total_pages": 110, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Control+Vehicle&page=15&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Control+Vehicle&page=13&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-18T15:48:16.384Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT04103060", "title": "Safety and Tolerability Study of Cerdulatinib Gel, 0.37% in Adults With Vitiligo", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Vitiligo" ], "interventions": [ { "name": "Cerdulatinib 0.37% gel", "type": "DRUG" }, { "name": "Vehicle gel", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Dermavant Sciences GmbH", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 33, "start_date": "2019-09-27", "completion_date": "2020-11-03", "has_results": false, "last_update_posted_date": "2020-11-24", "last_synced_at": "2026-10-18T15:48:16.384Z", "location_count": 2, "location_summary": "Irvine, California • Worcester, Massachusetts", "locations": [ { "city": "Irvine", "state": "California" }, { "city": "Worcester", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT04103060" }, { "nct_id": "NCT02564055", "title": "A Dose-Finding Study of GSK2894512 Cream in Subjects With Atopic Dermatitis (AD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Dermatitis, Atopic" ], "interventions": [ { "name": "GSK2894512 1% Cream", "type": "DRUG" }, { "name": "GSK2894512 0.5% Cream", "type": "DRUG" }, { "name": "Vehicle cream", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "12 Years to 65 Years" }, "enrollment_count": 247, "start_date": "2015-12-01", "completion_date": "2017-01-12", "has_results": true, "last_update_posted_date": "2017-11-20", "last_synced_at": "2026-10-18T15:48:16.384Z", "location_count": 36, "location_summary": "Fort Smith, Arkansas • Fresno, California • Irvine, California + 30 more", "locations": [ { "city": "Fort Smith", "state": "Arkansas" }, { "city": "Fresno", "state": "California" }, { "city": "Irvine", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Oceanside", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02564055" }, { "nct_id": "NCT03315689", "title": "Safety and Pharmacokinetic Study of ATI-50002 in Subjects With Alopecia Universalis (AU) and Alopecia Totalis (AT)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Alopecia Universalis (AU)", "Alopecia Totalis (AT)" ], "interventions": [ { "name": "Vehicle", "type": "DRUG" }, { "name": "ATI-50002", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Aclaris Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 11, "start_date": "2017-12-14", "completion_date": "2019-06-20", "has_results": true, "last_update_posted_date": "2020-07-02", "last_synced_at": "2026-10-18T15:48:16.384Z", "location_count": 2, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT03315689" }, { "nct_id": "NCT00700063", "title": "A Multicenter Study to Evaluate the Safety and Efficacy of PEP005 Topical Gel When Used to Treat Actinic Keratoses on the Head (Face or Scalp)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Actinic Keratosis" ], "interventions": [ { "name": "PEP005 Topical Gel", "type": "DRUG" }, { "name": "Vehicle gel", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Peplin", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 265, "start_date": "2008-06", "completion_date": "2008-10", "has_results": true, "last_update_posted_date": "2015-04-14", "last_synced_at": "2026-10-18T15:48:16.384Z", "location_count": 25, "location_summary": "Hot Springs, Arizona • Little Rock, Arkansas • Los Angeles, California + 20 more", "locations": [ { "city": "Hot Springs", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Riverside", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00700063" }, { "nct_id": "NCT00907335", "title": "A Study of Acne Treatment in Children Ages 9 to 11", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Acne Vulgaris" ], "interventions": [ { "name": "Retin-A Micro 0.04% facial acne treatment", "type": "DRUG" }, { "name": "Vehicle control", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Bausch Health Americas, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "9 Years", "maximum_age": "11 Years", "sex": "ALL", "summary": "9 Years to 11 Years" }, "enrollment_count": 110, "start_date": "2009-02", "completion_date": "2009-12", "has_results": true, "last_update_posted_date": "2012-02-15", "last_synced_at": "2026-10-18T15:48:16.384Z", "location_count": 12, "location_summary": "Encino, California • San Diego, California • Miami, Florida + 9 more", "locations": [ { "city": "Encino", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Miami", "state": "Florida" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Louisville", "state": "Kentucky" } ], "official_url": "https://clinicaltrials.gov/study/NCT00907335" }, { "nct_id": "NCT03888378", "title": "Study to Evaluate the Safety and Efficacy of Minocycline Ointment in Subjects With Inflamed Meibomian Gland Dysfunction", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Meibomian Gland Dysfunction", "MGD-Meibomian Gland Dysfunction" ], "interventions": [ { "name": "0.3% Topical Minocycline Ointment", "type": "DRUG" }, { "name": "1% Topical Minocycline Ointment", "type": "DRUG" }, { "name": "Topical Vehicle Ointment", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Hovione Scientia Limited", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 270, "start_date": "2019-04-02", "completion_date": "2021-02-01", "has_results": false, "last_update_posted_date": "2021-03-05", "last_synced_at": "2026-10-18T15:48:16.384Z", "location_count": 20, "location_summary": "Azusa, California • Huntington Beach, California • Inglewood, California + 16 more", "locations": [ { "city": "Azusa", "state": "California" }, { "city": "Huntington Beach", "state": "California" }, { "city": "Inglewood", "state": "California" }, { "city": "Mission Hills", "state": "California" }, { "city": "Rancho Cordova", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03888378" }, { "nct_id": "NCT04490109", "title": "B244 Topical Spray for the Treatment of Pruritus in Adults With a History of Atopic Dermatitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Atopic Dermatitis", "Pruritus" ], "interventions": [ { "name": "B244", "type": "BIOLOGICAL" }, { "name": "Vehicle", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "AOBiome LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 547, "start_date": "2020-06-24", "completion_date": "2022-01-07", "has_results": true, "last_update_posted_date": "2025-01-28", "last_synced_at": "2026-10-18T15:48:16.384Z", "location_count": 56, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • Scottsdale, Arizona + 50 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Bryant", "state": "Arkansas" }, { "city": "Little Rock", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT04490109" }, { "nct_id": "NCT04513652", "title": "A Study of the Safety and Anesthetic Effect of AG-920 Topical Ophthalmic Solution", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Anesthesia, Local" ], "interventions": [ { "name": "AG-920", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "American Genomics, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 120, "start_date": "2020-09-03", "completion_date": "2020-12-17", "has_results": true, "last_update_posted_date": "2022-09-28", "last_synced_at": "2026-10-18T15:48:16.384Z", "location_count": 1, "location_summary": "Newport Beach, California", "locations": [ { "city": "Newport Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04513652" }, { "nct_id": "NCT02661958", "title": "Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Acne Vulgaris" ], "interventions": [ { "name": "S6G5T-3", "type": "DRUG" }, { "name": "S6G5T-1", "type": "DRUG" }, { "name": "S6G5T-5", "type": "DRUG" }, { "name": "S6G5T-6", "type": "DRUG" }, { "name": "S6G5T-7", "type": "DRUG" }, { "name": "S6G5T-8", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sol-Gel Technologies, Ltd.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "9 Years", "maximum_age": null, "sex": "ALL", "summary": "9 Years and older" }, "enrollment_count": 726, "start_date": "2016-05", "completion_date": "2017-10", "has_results": false, "last_update_posted_date": "2019-09-19", "last_synced_at": "2026-10-18T15:48:16.384Z", "location_count": 34, "location_summary": "Anaheim, California • Cerritos, California • Chula Vista, California + 27 more", "locations": [ { "city": "Anaheim", "state": "California" }, { "city": "Cerritos", "state": "California" }, { "city": "Chula Vista", "state": "California" }, { "city": "Encino", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02661958" }, { "nct_id": "NCT00871208", "title": "Trial of Treatment of Atopic Dermatitis With Concurrent Altabax® and Topical Low-Potency Corticosteroids Versus Low-Potency Corticosteroid Mono-therapy", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Atopic Dermatitis" ], "interventions": [ { "name": "Altabax (R)", "type": "DRUG" }, { "name": "Vehicle and Locoid lipocream (R)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "St. Luke's-Roosevelt Hospital Center", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "9 Months", "maximum_age": "17 Years", "sex": "ALL", "summary": "9 Months to 17 Years" }, "enrollment_count": 0, "start_date": "2009-05", "completion_date": "2010-05", "has_results": false, "last_update_posted_date": "2015-05-12", "last_synced_at": "2026-10-18T15:48:16.384Z", "location_count": 3, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" }, { "city": "New York", "state": "New York" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00871208" } ] }